APA aipamena

Ono, A., Aikata, H., Yamauchi, M., Kodama, K., Ohishi, W., Kishi, T., . . . Chayama, K. (2020). Circulating cytokines and angiogenic factors based signature associated with the relative dose intensity during treatment in patients with advanced hepatocellular carcinoma receiving lenvatinib. Ther Adv Med Oncol.

Chicago Style aipamena

Ono, Atsushi, et al. "Circulating Cytokines and Angiogenic Factors Based Signature Associated With the Relative Dose Intensity During Treatment in Patients With Advanced Hepatocellular Carcinoma Receiving Lenvatinib." Ther Adv Med Oncol 2020.

MLA aipamena

Ono, Atsushi, et al. "Circulating Cytokines and Angiogenic Factors Based Signature Associated With the Relative Dose Intensity During Treatment in Patients With Advanced Hepatocellular Carcinoma Receiving Lenvatinib." Ther Adv Med Oncol 2020.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.